Alignment Healthcare Exceeds Q1 Expectations, Raises 2025 Guidance, Announces CFO Transition

ALHC
November 02, 2025

Alignment Healthcare, Inc. reported strong financial results for its first quarter ended March 31, 2025, exceeding the high-end of expectations across four critical key performance indicators. Total revenue for Q1 2025 reached $926.9 million, a 47.5% increase year-over-year, with health plan membership growing 32% to 209,900.

The company's adjusted gross profit surged by 70.3% to $110.5 million, and adjusted EBITDA improved significantly to $19.5 million, compared to a loss of $10.5 million in Q1 2024. The Medical Benefits Ratio improved to 87.9% from 90.7% in the prior year period, demonstrating enhanced operational efficiency.

Building on this performance, Alignment Healthcare raised its full-year 2025 financial guidance, now expecting revenue between $3.75 billion and $3.85 billion, adjusted gross profit between $440 million and $455 million, and adjusted EBITDA between $55 million and $65 million.

In a leadership change, Jim Head will succeed Thomas Freeman as Chief Financial Officer, effective May 2, 2025. Freeman will transition to a Strategic Advisor role to the CEO, ensuring a smooth handover and continued support for the company's long-term strategy.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.